Millions of syringe products in chaos as FDA probes China-made devices

At least 60 million syringes and infusion pumps are in turmoil as the FDA investigates China-made plastic syringes that changed dimensions. 

Advertisement

On Nov. 30, the FDA warned healthcare workers to avoid plastic syringes made in China after several manufacturers changed syringe dimensions, which the agency said is causing leaks and breakage. 

In the two weeks prior to the FDA’s warning, U.S. medical devicemakers issued warnings about their syringe infusion pumps having compatibility issues with modified syringes, including 32 million Cardinal Health syringes that have different dimensions than older brands.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.